Cardiac troponin levels serve as a pivotal parameter in the evaluation and understanding of cardiac health. These troponins, specific proteins located in cardiac muscle cells, act as valuable biomarkers that can signify myocardial injury. The release of troponins into the bloodstream becomes particularly relevant in scenarios such as heart attacks or other cardiac events. A surge in troponin levels corresponds to damage to the heart muscle, providing healthcare professionals with a reliable diagnostic indicator. The advancements in high sensitivity troponin assays have remarkably increased the precision of detecting even minor cardiac injuries, allowing for prompt intervention and enhancing overall patient outcomes. Beyond the acute phase, continuous monitoring of troponin levels proves beneficial in assessing the progression of heart damage and guiding ongoing treatment plans. In the evolving landscape of cardiology, the measurement of cardiac troponin levels stands as an indispensable tool, contributing significantly to improved patient care and the advancement of cardiac science.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom